Crossmark

Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2022.06.001

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gutiérrez-Rojas, Luis http://orcid.org/0000-0003-0082-2189
de la Gándara Martín, Jesús José

García Buey, Luisa

Uriz Otano, Juan I.

Mena, Álvaro

Roncero, Carlos
Funding

Funding for this research was provided by:

AbbVie

Gilead Sciences

AbbVie
License Information

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2022-06-17
More Information

This article is maintained by: Elsevier

Article Title: Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2022.06.001

Content Type: article

Copyright: © 2022 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below